Table 1. Individual characteristics according to variables in patients with hemophilia A from 1998 to 2008.
| Variables | Rehabilitation users (n = 321) | Rehabilitation non-users (n = 456) | P |
|---|---|---|---|
| Gender | 0.296 | ||
| Male | 311 (96.9%) | 435 (95.4%) | |
| Female | 10 (3.1%) | 21 (4.6%) | |
| Mean age (years) | 0.002 | ||
| < 20 | 109 (34.0%) | 215 (47.2%) | |
| 20 to < 36 | 108 (33.6%) | 137 (30.0%) | |
| 36 to < 51 | 71 (22.1%) | 71 (15.6%) | |
| ≥ 51 | 33 (10.3%) | 33 (7.2%) | |
| Mean insured amount per month | <0.001 | ||
| < USD 528 | 183 (57.0%) | 320 (70.2%) | |
| ≥ USD 528 | 138 (43.0%) | 136 (29.8%) | |
| Urbanization level* | 0.266 | ||
| 1 (most urbanized) | 96 (29.9%) | 123 (27.0%) | |
| 2 | 108 (33.6%) | 133 (29.2%) | |
| 3 | 52 (16.2%) | 102 (22.4%) | |
| 4 | 41 (12.8%) | 66 (14.4%) | |
| 5 | 7 (2.2%) | 6 (1.3%) | |
| 6 | 10 (3.1%) | 19 (4.2%) | |
| 7 (least urbanized) | 7 (2.2%) | 7 (1.5%) | |
| Musculoskeletal or neurological surgical procedures | <0.001 | ||
| Yes | 141 (43.9%) | 67 (14.7%) | |
| No | 180 (56.1%) | 389 (85.3%) | |
| Total costs (USD) for clotting factor VIII concentrates | 545,762 ± 602,351 | 341,582 ± 445,437 | <0.001 |
| Total costs (USD) for bypass agents | 53,641 ± 273,364 | 380 ± 5,622 | <0.001 |
| Mean cost (USD) for rehabilitation | 843 (3–38402) | 0 |
USD, United States dollar.
*The urbanization level of each patient was determined according to the median value of urbanization level in the database from 1998 to 2008.